The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Aortic Stenosis and Cardiac Amyloidosis
Open accessAbstract
The prevalence of calcific aortic stenosis (AS) and of cardiac amyloidosis (CA) increases with age, and their association is not uncommon in the elderly. The identification of CA is particularly challenging in patients with AS because these 2 conditions share several features. It is estimated that ≤15% of the AS population and ≤30% of the subset with low-flow, low-gradient pattern may have CA. In patients with AS, CA is associated with increased risk of heart failure, mortality, and treatment futility with aortic valve replacement. In case of suspicion of CA, it is thus crucial to confirm the diagnosis to guide therapeutic management of AS and eventually implement recently developed pharmacological treatment dedicated to transthyretin amyloidosis. Given the high surgical risk of patients with AS and concomitant CA, transcatheter aortic valve replacement may be preferred to surgery in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Self-citationNonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationWild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
González-López, E., Gallego-Delgado, M., Guzzo-Merello, G., de Haro-del Moral, F. J., Cobo-Marcos, M., Robles, C., Bornstein, B., Salas, C., Lara-Pezzi, E., Alonso-Pulpon, L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv338 · Cited by 1,174
Transthyretin Amyloid Cardiomyopathy
Ruberg, F. L., Grogan, M., Hanna, M., Kelly, J. W., & Maurer, M. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.003 · Cited by 1,112
Zhang, J., Gajjala, S., Agrawal, P., Tison, G. H., Hallock, L. A., Beussink-Nelson, L., Lassen, M. H., Fan, E., Aras, M. A., Jordan, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034338 · Cited by 1,006
Perugini, E., Guidalotti, P. L., Salvi, F., Cooke, R. M. T., Pettinato, C., Riva, L., Leone, O., Farsad, M., Ciliberti, P., Bacchi-Reggiani, L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.073 · Cited by 981
A new staging system for cardiac transthyretin amyloidosis
Gillmore, J. D., Damy, T., Fontana, M., Hutchinson, M., Lachmann, H. J., Martinez-Naharro, A., Quarta, C. C., Rezk, T., Whelan, C. J., Gonzalez-Lopez, E., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx589 · Cited by 776
Self-citationCastaño, A., Narotsky, D. L., Hamid, N., Khalique, O. K., Morgenstern, R., DeLuca, A., Rubin, J., Chiuzan, C., Nazif, T., Vahl, T., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx350 · Cited by 726
Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis
Karamitsos, T. D., Piechnik, S. K., Banypersad, S. M., Fontana, M., Ntusi, N. B., Ferreira, V. M., Whelan, C. J., Myerson, S. G., Robson, M. D., Hawkins, P. N., et al. (2013) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2012.11.013 · Cited by 676
Tanskanen, M., Peuralinna, T., Polvikoski, T., Notkola, I., Sulkava, R., Hardy, J., Singleton, A., Kiuru‐Enari, S., Paetau, A., Tienari, P. J., et al. (2008) · Annals of Medicine · doi:10.1080/07853890701842988 · Cited by 591
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis
Maurer, M. S., Hanna, M., Grogan, M., Dispenzieri, A., Witteles, R., Drachman, B., Judge, D. P., Lenihan, D. J., Gottlieb, S. S., Shah, S. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.596 · Cited by 538
Self-citationFrequency and distribution of senile cardiovascular amyloid
Cornwell, G. G., Murdoch, W. L., Kyle, R. A., Westermark, P., & Pitkänen, P. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90443-6 · Cited by 483
Clavel, M.-A., Pibarot, P., Messika-Zeitoun, D., Capoulade, R., Malouf, J., Aggarwal, S. R., Araoz, P. A., Michelena, H. I., Cueff, C., Larose, E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.066 · Cited by 480
Self-citationSolomon, S. D., Adams, D., Kristen, A., Grogan, M., González-Duarte, A., Maurer, M. S., Merlini, G., Damy, T., Slama, M. S., Brannagan, T. H., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035831 · Cited by 462
Self-citationNative T1 Mapping in Transthyretin Amyloidosis
Fontana, M., Banypersad, S. M., Treibel, T. A., Maestrini, V., Sado, D. M., White, S. K., Pica, S., Castelletti, S., Piechnik, S. K., Robson, M. D., et al. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.10.008 · Cited by 432
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
González-López, E., Gagliardi, C., Dominguez, F., Quarta, C. C., de Haro-del Moral, F. J., Milandri, A., Salas, C., Cinelli, M., Cobo-Marcos, M., Lorenzini, M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx043 · Cited by 376
Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release
Sperry, B. W., Reyes, B. A., Ikram, A., Donnelly, J. P., Phelan, D., Jaber, W. A., Shapiro, D., Evans, P. J., Maschke, S., Kilpatrick, S. E., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.092 · Cited by 358
Treibel, T. A., Fontana, M., Gilbertson, J. A., Castelletti, S., White, S. K., Scully, P. R., Roberts, N., Hutt, D. F., Rowczenio, D. M., Whelan, C. J., et al. (2016) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005066 · Cited by 317
Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis
Feng, D., Edwards, W. D., Oh, J. K., Chandrasekaran, K., Grogan, M., Martinez, M. W., Syed, I. I., Hughes, D. A., Lust, J. A., Jaffe, A. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.697763 · Cited by 305
Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis
Feng, D., Syed, I. S., Martinez, M., Oh, J. K., Jaffe, A. S., Grogan, M., Edwards, W. D., Gertz, M. A., & Klarich, K. W. (2009) · Circulation · doi:10.1161/circulationaha.108.785014 · Cited by 283
Austin, B. A., Tang, W. H. W., Rodriguez, E. R., Tan, C., Flamm, S. D., Taylor, D. O., Starling, R. C., & Desai, M. Y. (2009) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.08.008 · Cited by 260
Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis
Cavalcante, J. L., Rijal, S., Abdelkarim, I., Althouse, A. D., Sharbaugh, M. S., Fridman, Y., Soman, P., Forman, D. E., Schindler, J. T., Gleason, T. G., et al. (2016) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-017-0415-x · Cited by 220
Ternacle, J., Bodez, D., Guellich, A., Audureau, E., Rappeneau, S., Lim, P., Radu, C., Guendouz, S., Couetil, J.-P., Benhaiem, N., et al. (2016) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.05.014 · Cited by 214
Self-citationDamy, T., Kristen, A. V., Suhr, O. B., Maurer, M. S., Planté-Bordeneuve, V., Yu, C.-R., Ong, M.-L., Coelho, T., Rapezzi, C., & THAOS Investigators (2022) · European Heart Journal · doi:10.1093/eurheartj/ehz173 · Cited by 177
Self-citationYanagisawa, A., Ueda, M., Sueyoshi, T., Okada, T., Fujimoto, T., Ogi, Y., Kitagawa, K., Tasaki, M., Misumi, Y., Oshima, T., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.102 · Cited by 161
Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?
Galat, A., Guellich, A., Bodez, D., Slama, M., Dijos, M., Messika–Zeitoun, D., Milleron, O., Attias, D., Dubois‐Randé, J., Mohty, D., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw033 · Cited by 151
Self-citationFosbøl, E. L., Rørth, R., Leicht, P., Schou, M., Maurer, M. S., Kristensen, S. L., Køber, L., & Gustafsson, F. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.054 · Cited by 137
Kristen, A. V., Schnabel, P. A., Winter, B., Helmke, B. M., Longerich, T., Hardt, S. E., Koch, A., Sack, F., Katus, H. A., LINKE, R. P., et al. (2009) · Cardiovascular Pathology · doi:10.1016/j.carpath.2009.04.005 · Cited by 105
Hamon, D., Algalarrondo, V., Gandjbakhch, E., Extramiana, F., Marijon, É., Elbaz, N., Selhane, D., Dubois‐Randé, J., Teíger, E., Planté‐Bordeneuve, V., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.254 · Cited by 104
Self-citationTransthyretin V122I in African Americans With Congestive Heart Failure
Buxbaum, J. N., Jacobson, D. R., Tagoe, C. E., Alexander, A. A., Kitzman, D. W., Greenberg, B., Thaneemit-Chen, S., & Lavori, P. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.01.042 · Cited by 92
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?
Muchtar, E., Gertz, M. A., Kumar, S. K., Lin, G., Boilson, B. A., Clavell, A. L., Lacy, M. Q., Buadi, F. K., Hayman, S. R., Kapoor, P., et al. (2018) · Amyloid · doi:10.1080/13506129.2018.1449744 · Cited by 89
Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy
Damy, T., Maurer, M. S., Rapezzi, C., Planté‐Bordeneuve, V., Karayal, O. N., Mundayat, R., Suhr, O. B., & Kristen, A. V. (2016) · Open Heart · doi:10.1136/openhrt-2015-000289 · Cited by 87
Self-citationPathology of Transcatheter Valve Therapy
Nietlispach, F., Webb, J. G., Ye, J., Cheung, A. W., Lichtenstein, S. V., Carere, R. G., Gurvitch, R., Thompson, C., Ostry, A. J., Matzke, L. A. M., et al. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.03.012 · Cited by 86
Kristen, A. V., Maurer, M. S., Rapezzi, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173086 · Cited by 81
Amyloid substance within stenotic aortic valves promotes mineralization
Audet, A., Côté, N., Couture, C., Bossé, Y., Després, J., Pîbarot, P., & Mathieu, P. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04265.x · Cited by 69
Self-citationRecognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis
Sperry, B. W., Jones, B., Vranian, M. N., Hanna, M. A., & Jaber, W. A. (2016) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2015.10.023 · Cited by 64
Kimber, J. R., Sabzwari, S. R. A., Mann, K., Ayele, H., Bozorgnia, B., & Dusaj, R. (2019) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(19)33478-3 · Cited by 46
Cardiovascular magnetic resonance imaging for amyloidosis: The state-of-the-art
Tang, C. X., Petersen, S. E., Sanghvi, M. M., Lu, G., & Zhang, L. J. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.06.011 · Cited by 27
Cited by
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Beyersdorf, F., Vahanian, A., Milojevic, M., Praz, F., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2021) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezab389 · Cited by 622
Self-citationPrevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis
Nitsche, C., Scully, P. R., Patel, K. P., Kammerlander, A. A., Koschutnik, M., Dona, C., Wollenweber, T., Ahmed, N., Thornton, G. D., Kelion, A. D., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.006 · Cited by 377
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · EuroIntervention · doi:10.4244/eij-e-21-00009 · Cited by 372
Multi-modality imaging in aortic stenosis: an EACVI clinical consensus document
Dweck, M. R., Loganath, K., Bing, R., Treibel, T. A., McCann, G. P., Newby, D. E., Leipsic, J., Fraccaro, C., Paolisso, P., Cosyns, B., et al. (2023) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jead153 · Cited by 79
Self-citation
Metadata
- Authors
- Ternacle, J., Krapf, L., Mohty, D., Magne, J., Nguyen, A., Galat, A., Gallet, R., Teiger, E., Côté, N., Clavel, M.-A., Tournoux, F., Pibarot, P., & Damy, T.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 74
- Issue
- 21
- Pages
- 2638-2651
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2987952648
- Cited by
- 294
- References
- 42
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.